The pandemic brought about a lot of interest in the topic of immunity in the consumer health industry. Many pharmaceutical companies, including the renowned French company Sanofi, have started establishing vaccine facilities to combat future pandemics. Sanofi opened a vaccine facility in Singapore in April 2022, joining other global pharmaceutical players in this endeavour. The increased focus on immunity in Singapore has raised concerns about sleep duration amongst its residents.
The Sleep Aids in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Sleep Aids in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Sleep Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
- SLEEP AIDS IN SINGAPORE
- KEY DATA FINDINGS
- 2023 DEVELOPMENTS
- Subject of immunity sparks consumers’ interest in sleep sufficiency
- Melatonin and vitamin B6 remain the most popular ingredients for sleep aids
- Preference for herbal/traditional
